Company Filing History:
Years Active: 2017-2021
Title: Innovations in Cancer Treatment by Shreyans Kumar Jain
Introduction
Shreyans Kumar Jain is a prominent inventor based in Jammu, India, known for his contributions to cancer research through innovative chemical compounds. With a total of four patents to his name, Jain has made significant strides in developing new therapeutic agents to combat various types of cancer.
Latest Patents
Two of Shreyans Kumar Jain's latest patents include:
1. **Indolylkojyl Methane Analogues**: This invention discloses novel indolylkojyl compounds that demonstrate selective toxicity towards human breast cancer cells, inhibiting tumor growth and lung metastasis. The innovative aspect of this patent includes a one-pot, green chemistry method for the preparation of these indolylkojyl compounds, enhancing their potential as effective anticancer agents.
2. **Rohitukine Analogs as Cyclin-Dependent Kinase Inhibitors**: This patent relates to the rohitukine analogs, which are designed to treat or prevent various proliferative disorders, such as melanoma, leukemia, breast cancer, and prostate cancer. Along with providing pharmaceutically acceptable salts of these compounds, the patent includes methods for their use, showcasing a comprehensive approach to cancer treatment.
Career Highlights
Shreyans Kumar Jain is affiliated with the Council of Scientific & Industrial Research, where he actively engages in research that bridges chemistry and medicine. His work focuses on leveraging chemical innovations to develop therapies that target cancer cells more effectively.
Collaborations
Throughout his career, Jain has collaborated with notable colleagues, including Ram Asrey Vishwakarma and Sandip Bibishan Bharate. These partnerships enhance the research endeavors and result in a richer exchange of ideas and findings within the field of cancer treatment.
Conclusion
Shreyans Kumar Jain's pioneering work in developing new cancer therapies underscores the importance of innovation in medical research. His patents not only contribute to the scientific community but also hold promise for improving treatment outcomes for cancer patients.